Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 lossesInvezz • 05/10/24
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop combination shotsCNBC • 05/10/24
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination VaccinesPRNewsWire • 05/10/24
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccinesGlobeNewsWire • 05/10/24
INHIBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inhibrx, Inc. - INBXBusiness Wire • 05/09/24
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizationsGlobeNewsWire • 05/02/24
AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers LagsInvestors Business Daily • 04/25/24
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidanceGlobeNewsWire • 04/25/24
FTC looking to accelerate inquiry into prescription-drug middlemen, chair saysMarket Watch • 04/23/24
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopeniaGlobeNewsWire • 04/23/24